Tobacco control: Reducing cancer incidence and saving lives

Allen S. Lichter, Mary Ann Allison, Jacob D. Bitran, Nancy E. Davidson, Steven M. Grunberg, Francine E. Halberg, Alexander W. Kennedy, Michael Paul Link, Kenneth Offit, Howard Ozer, Peter T. Scardino, Lowell E. Schnipper, Lawrence N. Shulman, Ellen L. Stovall, Nicholas J. Vogelzang, Barbara L. Weber

Research output: Contribution to journalArticle

Abstract

Introduction: The American Society of Clinical Oncology (ASCO) supports the elimination of tobacco products. Toward that goal, ASCO urges the adoption of national policy that strengthens regulation of the sale, promotion, and distribution of such products. To reduce cancer mortality, our regulatory policies must recognize that the nicotine within tobacco is an addictive substance, the use of which leads to 30% of all cancer deaths and a total of 419,000 deaths each year. Restricting Advertising and Promotion: Tobacco-related advertising and promotion should be banned. At a minimum, national policies should: ban billboards; limit advertising to black and white text only; prohibit the sale or giveaway of products that contain tobacco brand names or logos; prohibit brand name sponsorship of sporting or entertainment events; and require stronger and more prominent warning labels on all tobacco products. Restricting Access by Children and Teenagers: Despite existing state laws prohibiting sale of tobacco products to minors, children are able to buy such products easily. National regulation of the sale and distribution of tobacco products is necessary to eliminate children's access to tobacco. Where sales are permitted, they should be limited to face-to-face purchases by individuals 18 and older. Vending machines and other means of distributing tobacco without a face-to-face purchase should be outlawed. Enhancing Public Education: To the extent tobacco sales are allowed to continue, the federal government should mandate that the tobacco industry contribute substantial funds for a national public education campaign to prevent young people from smoking and other tobacco use. Raising Tobacco Excise Taxes: ASCO has long advocated a substantial increase (in the range of $2) in the federal excise tax on cigarettes and other tobacco products-a measure known to decrease consumption, particularly among children. Revenue from a tax on tobacco products should be used to support retraining for tobacco farmers, biomedical research, health care delivery, and antitobacco education. Controlling Tobacco Exports: United States trade policies should discourage the export of tobacco products and manufacturing to foreign markets. At a minimum, United States tobacco companies selling or manufacturing tobacco products in foreign markets that have not developed comparable health warning labels should be required to retain United States warning labels. Taking Responsibility as Health Care Professionals: Physicians, nurses, and other health care professionals- especially those in primary care disciplines-have the opportunity and responsibility to assist patients' efforts to quit tobacco use and to ensure that nonsmokers continue to avoid the addiction. Oncology specialists should discuss the causal relationship between tobacco use and cancer as well as a variety of other chronic diseases and assist, as required, the patient and family members to end tobacco dependency. In addition, health care professionals must advocate that public and private insurers be required to provide health care coverage for medically necessary interventions, such as counseling and nicotine transdermal systems.

Original languageEnglish (US)
Pages (from-to)1961-1963
Number of pages3
JournalJournal of Clinical Oncology
Volume14
Issue number6
StatePublished - Jun 1996
Externally publishedYes

Fingerprint

Tobacco Products
Tobacco
Incidence
Neoplasms
Delivery of Health Care
Tobacco Use
Medical Oncology
Nicotine
Education
Names
Tobacco Industry
Minors
Insurance Carriers
Federal Government
Taxes
Financial Management
Biomedical Research
Counseling
Primary Health Care
Chronic Disease

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lichter, A. S., Allison, M. A., Bitran, J. D., Davidson, N. E., Grunberg, S. M., Halberg, F. E., ... Weber, B. L. (1996). Tobacco control: Reducing cancer incidence and saving lives. Journal of Clinical Oncology, 14(6), 1961-1963.

Tobacco control : Reducing cancer incidence and saving lives. / Lichter, Allen S.; Allison, Mary Ann; Bitran, Jacob D.; Davidson, Nancy E.; Grunberg, Steven M.; Halberg, Francine E.; Kennedy, Alexander W.; Link, Michael Paul; Offit, Kenneth; Ozer, Howard; Scardino, Peter T.; Schnipper, Lowell E.; Shulman, Lawrence N.; Stovall, Ellen L.; Vogelzang, Nicholas J.; Weber, Barbara L.

In: Journal of Clinical Oncology, Vol. 14, No. 6, 06.1996, p. 1961-1963.

Research output: Contribution to journalArticle

Lichter, AS, Allison, MA, Bitran, JD, Davidson, NE, Grunberg, SM, Halberg, FE, Kennedy, AW, Link, MP, Offit, K, Ozer, H, Scardino, PT, Schnipper, LE, Shulman, LN, Stovall, EL, Vogelzang, NJ & Weber, BL 1996, 'Tobacco control: Reducing cancer incidence and saving lives', Journal of Clinical Oncology, vol. 14, no. 6, pp. 1961-1963.
Lichter AS, Allison MA, Bitran JD, Davidson NE, Grunberg SM, Halberg FE et al. Tobacco control: Reducing cancer incidence and saving lives. Journal of Clinical Oncology. 1996 Jun;14(6):1961-1963.
Lichter, Allen S. ; Allison, Mary Ann ; Bitran, Jacob D. ; Davidson, Nancy E. ; Grunberg, Steven M. ; Halberg, Francine E. ; Kennedy, Alexander W. ; Link, Michael Paul ; Offit, Kenneth ; Ozer, Howard ; Scardino, Peter T. ; Schnipper, Lowell E. ; Shulman, Lawrence N. ; Stovall, Ellen L. ; Vogelzang, Nicholas J. ; Weber, Barbara L. / Tobacco control : Reducing cancer incidence and saving lives. In: Journal of Clinical Oncology. 1996 ; Vol. 14, No. 6. pp. 1961-1963.
@article{44fcaaf600d54f4997fcc2570978d886,
title = "Tobacco control: Reducing cancer incidence and saving lives",
abstract = "Introduction: The American Society of Clinical Oncology (ASCO) supports the elimination of tobacco products. Toward that goal, ASCO urges the adoption of national policy that strengthens regulation of the sale, promotion, and distribution of such products. To reduce cancer mortality, our regulatory policies must recognize that the nicotine within tobacco is an addictive substance, the use of which leads to 30{\%} of all cancer deaths and a total of 419,000 deaths each year. Restricting Advertising and Promotion: Tobacco-related advertising and promotion should be banned. At a minimum, national policies should: ban billboards; limit advertising to black and white text only; prohibit the sale or giveaway of products that contain tobacco brand names or logos; prohibit brand name sponsorship of sporting or entertainment events; and require stronger and more prominent warning labels on all tobacco products. Restricting Access by Children and Teenagers: Despite existing state laws prohibiting sale of tobacco products to minors, children are able to buy such products easily. National regulation of the sale and distribution of tobacco products is necessary to eliminate children's access to tobacco. Where sales are permitted, they should be limited to face-to-face purchases by individuals 18 and older. Vending machines and other means of distributing tobacco without a face-to-face purchase should be outlawed. Enhancing Public Education: To the extent tobacco sales are allowed to continue, the federal government should mandate that the tobacco industry contribute substantial funds for a national public education campaign to prevent young people from smoking and other tobacco use. Raising Tobacco Excise Taxes: ASCO has long advocated a substantial increase (in the range of $2) in the federal excise tax on cigarettes and other tobacco products-a measure known to decrease consumption, particularly among children. Revenue from a tax on tobacco products should be used to support retraining for tobacco farmers, biomedical research, health care delivery, and antitobacco education. Controlling Tobacco Exports: United States trade policies should discourage the export of tobacco products and manufacturing to foreign markets. At a minimum, United States tobacco companies selling or manufacturing tobacco products in foreign markets that have not developed comparable health warning labels should be required to retain United States warning labels. Taking Responsibility as Health Care Professionals: Physicians, nurses, and other health care professionals- especially those in primary care disciplines-have the opportunity and responsibility to assist patients' efforts to quit tobacco use and to ensure that nonsmokers continue to avoid the addiction. Oncology specialists should discuss the causal relationship between tobacco use and cancer as well as a variety of other chronic diseases and assist, as required, the patient and family members to end tobacco dependency. In addition, health care professionals must advocate that public and private insurers be required to provide health care coverage for medically necessary interventions, such as counseling and nicotine transdermal systems.",
author = "Lichter, {Allen S.} and Allison, {Mary Ann} and Bitran, {Jacob D.} and Davidson, {Nancy E.} and Grunberg, {Steven M.} and Halberg, {Francine E.} and Kennedy, {Alexander W.} and Link, {Michael Paul} and Kenneth Offit and Howard Ozer and Scardino, {Peter T.} and Schnipper, {Lowell E.} and Shulman, {Lawrence N.} and Stovall, {Ellen L.} and Vogelzang, {Nicholas J.} and Weber, {Barbara L.}",
year = "1996",
month = "6",
language = "English (US)",
volume = "14",
pages = "1961--1963",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "6",

}

TY - JOUR

T1 - Tobacco control

T2 - Reducing cancer incidence and saving lives

AU - Lichter, Allen S.

AU - Allison, Mary Ann

AU - Bitran, Jacob D.

AU - Davidson, Nancy E.

AU - Grunberg, Steven M.

AU - Halberg, Francine E.

AU - Kennedy, Alexander W.

AU - Link, Michael Paul

AU - Offit, Kenneth

AU - Ozer, Howard

AU - Scardino, Peter T.

AU - Schnipper, Lowell E.

AU - Shulman, Lawrence N.

AU - Stovall, Ellen L.

AU - Vogelzang, Nicholas J.

AU - Weber, Barbara L.

PY - 1996/6

Y1 - 1996/6

N2 - Introduction: The American Society of Clinical Oncology (ASCO) supports the elimination of tobacco products. Toward that goal, ASCO urges the adoption of national policy that strengthens regulation of the sale, promotion, and distribution of such products. To reduce cancer mortality, our regulatory policies must recognize that the nicotine within tobacco is an addictive substance, the use of which leads to 30% of all cancer deaths and a total of 419,000 deaths each year. Restricting Advertising and Promotion: Tobacco-related advertising and promotion should be banned. At a minimum, national policies should: ban billboards; limit advertising to black and white text only; prohibit the sale or giveaway of products that contain tobacco brand names or logos; prohibit brand name sponsorship of sporting or entertainment events; and require stronger and more prominent warning labels on all tobacco products. Restricting Access by Children and Teenagers: Despite existing state laws prohibiting sale of tobacco products to minors, children are able to buy such products easily. National regulation of the sale and distribution of tobacco products is necessary to eliminate children's access to tobacco. Where sales are permitted, they should be limited to face-to-face purchases by individuals 18 and older. Vending machines and other means of distributing tobacco without a face-to-face purchase should be outlawed. Enhancing Public Education: To the extent tobacco sales are allowed to continue, the federal government should mandate that the tobacco industry contribute substantial funds for a national public education campaign to prevent young people from smoking and other tobacco use. Raising Tobacco Excise Taxes: ASCO has long advocated a substantial increase (in the range of $2) in the federal excise tax on cigarettes and other tobacco products-a measure known to decrease consumption, particularly among children. Revenue from a tax on tobacco products should be used to support retraining for tobacco farmers, biomedical research, health care delivery, and antitobacco education. Controlling Tobacco Exports: United States trade policies should discourage the export of tobacco products and manufacturing to foreign markets. At a minimum, United States tobacco companies selling or manufacturing tobacco products in foreign markets that have not developed comparable health warning labels should be required to retain United States warning labels. Taking Responsibility as Health Care Professionals: Physicians, nurses, and other health care professionals- especially those in primary care disciplines-have the opportunity and responsibility to assist patients' efforts to quit tobacco use and to ensure that nonsmokers continue to avoid the addiction. Oncology specialists should discuss the causal relationship between tobacco use and cancer as well as a variety of other chronic diseases and assist, as required, the patient and family members to end tobacco dependency. In addition, health care professionals must advocate that public and private insurers be required to provide health care coverage for medically necessary interventions, such as counseling and nicotine transdermal systems.

AB - Introduction: The American Society of Clinical Oncology (ASCO) supports the elimination of tobacco products. Toward that goal, ASCO urges the adoption of national policy that strengthens regulation of the sale, promotion, and distribution of such products. To reduce cancer mortality, our regulatory policies must recognize that the nicotine within tobacco is an addictive substance, the use of which leads to 30% of all cancer deaths and a total of 419,000 deaths each year. Restricting Advertising and Promotion: Tobacco-related advertising and promotion should be banned. At a minimum, national policies should: ban billboards; limit advertising to black and white text only; prohibit the sale or giveaway of products that contain tobacco brand names or logos; prohibit brand name sponsorship of sporting or entertainment events; and require stronger and more prominent warning labels on all tobacco products. Restricting Access by Children and Teenagers: Despite existing state laws prohibiting sale of tobacco products to minors, children are able to buy such products easily. National regulation of the sale and distribution of tobacco products is necessary to eliminate children's access to tobacco. Where sales are permitted, they should be limited to face-to-face purchases by individuals 18 and older. Vending machines and other means of distributing tobacco without a face-to-face purchase should be outlawed. Enhancing Public Education: To the extent tobacco sales are allowed to continue, the federal government should mandate that the tobacco industry contribute substantial funds for a national public education campaign to prevent young people from smoking and other tobacco use. Raising Tobacco Excise Taxes: ASCO has long advocated a substantial increase (in the range of $2) in the federal excise tax on cigarettes and other tobacco products-a measure known to decrease consumption, particularly among children. Revenue from a tax on tobacco products should be used to support retraining for tobacco farmers, biomedical research, health care delivery, and antitobacco education. Controlling Tobacco Exports: United States trade policies should discourage the export of tobacco products and manufacturing to foreign markets. At a minimum, United States tobacco companies selling or manufacturing tobacco products in foreign markets that have not developed comparable health warning labels should be required to retain United States warning labels. Taking Responsibility as Health Care Professionals: Physicians, nurses, and other health care professionals- especially those in primary care disciplines-have the opportunity and responsibility to assist patients' efforts to quit tobacco use and to ensure that nonsmokers continue to avoid the addiction. Oncology specialists should discuss the causal relationship between tobacco use and cancer as well as a variety of other chronic diseases and assist, as required, the patient and family members to end tobacco dependency. In addition, health care professionals must advocate that public and private insurers be required to provide health care coverage for medically necessary interventions, such as counseling and nicotine transdermal systems.

UR - http://www.scopus.com/inward/record.url?scp=8944261369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8944261369&partnerID=8YFLogxK

M3 - Article

C2 - 8656267

AN - SCOPUS:8944261369

VL - 14

SP - 1961

EP - 1963

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 6

ER -